About this trial
This is a prospective longitudinal study aimed at better understanding the determinants of the prognosis of patients with substance dependence.
5 visits are planned during the study :
* the inclusion visit : during this visit the patient's non-opposition is obtained and then the patient answer to self-administered questionnaires online * 4 telephone interviews for follow-up by investigator.
Eligibility criteria
Qualifiers
Patients between 18 and 65 years old
Patients with a use-related disorder as defined by DSM5
Patients weaning for a substance, supported within the addictology sector of Henri Laborit Hospital
Having expressed non-opposition to participating in the study after receiving written information.
Disqualifiers
Person who cannot read or write
Simultaneous participation in a therapeutic trial involving oxytocin
Patients protected by law
Patients who do not have French as their native language
Trial design
Treatments tested in this trial
- Questionnaires